Obesity Trial, Recruiting NCT06254768 Sponsor: University of California, Los Angeles Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06254768
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 10 to 21 years old whose BMI is above the 95th percentile for their age (this means their weight is higher than 95% of people the same age, which doctors consider obesity)

Who may not be able to join:

  • People who have previously been diagnosed with Prader-Willi Syndrome or obesity caused by a brain region called the hypothalamus
  • People who have an intellectual disability
  • People who have had weight-loss (bariatric) surgery in the past, or who are planning to have it
  • People whose HbA1c blood sugar test result is above 6.5% (this is a test that checks average blood sugar levels over time, and a result above this level may suggest diabetes)
  • People who are currently taking any medication that affects body weight

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Steven D Mittelman, MD, PhD, University of California, Los Angeles

Phone: 9177414080

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 January 2023
Est. completion
1 March 2024

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of continuous glucose monitor(CGM) use in children and adolescents with obesity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov